Aligos Therapeutics Inc (ALGS)

03:31 AM

Charles Schwab Investment Management Inc. Buys 2,306 Shares of Aligos Therapeutics, Inc. (NASDAQ:ALGS) - Defense World

03:31 AM

Mar 29, 2025

Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 29, 2025

Mar 26, 2025

(ALGS) Long Term Investment Analysis - Stock Traders Daily

Mar 26, 2025

Mar 26, 2025

Aligos Therapeutics Presents Positive Data at APASL 2025 - The Manila Times

Mar 26, 2025

Mar 26, 2025

Clinical Trial Success: Aligos' Dual Breakthroughs in Liver Disease Show 100% Efficacy - Stock Titan

Mar 26, 2025

Mar 24, 2025

Ten option delistings on March 24th - TipRanks

Mar 24, 2025

Mar 21, 2025

Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter

Mar 21, 2025

Mar 16, 2025

Learn to Evaluate (ALGS) using the Charts - news.stocktradersdaily.com

Mar 16, 2025

Mar 14, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 14, 2025

Mar 14, 2025

Aligos Therapeutics Expands Team with Strategic Stock Option Package - Stock Titan

Mar 14, 2025

Mar 14, 2025

HC Wainwright Issues Negative Outlook for ALGS Earnings - Defense World

Mar 14, 2025

Mar 14, 2025

Financial Comparison: Achilles Therapeutics (NASDAQ:ACHL) vs. Aligos Therapeutics (NASDAQ:ALGS) - Defense World

Mar 14, 2025

Mar 12, 2025

H.C. Wainwright cuts Aligos stock target to $70, maintains Buy By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

H.C. Wainwright cuts Aligos stock target to $70, maintains Buy - Investing.com India

Mar 12, 2025

Mar 12, 2025

Aligos Therapeutics (NASDAQ:ALGS) Price Target Lowered to $70.00 at HC Wainwright - Defense World

Mar 12, 2025

Mar 12, 2025

Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition - TipRanks

Mar 12, 2025

Mar 10, 2025

Aligos Therapeutics Advances Pipeline Amid Financial Challenges - TipRanks

Mar 10, 2025

Mar 10, 2025

Aligos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 10, 2025

Mar 10, 2025

Aligos Therapeutics reports fourth-quarter and full-year 2024 results -March 10, 2025 at 10:48 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

ALIGOS THERAPEUTICS Earnings Results: $ALGS Reports Quarterly Earnings - Nasdaq

Mar 10, 2025

Mar 10, 2025

Aligos Therapeutics reports Q4 EPS ($13.08) vs ($5.50) last year - TipRanks

Mar 10, 2025

Mar 10, 2025

Aligos Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 10, 2025

Mar 10, 2025

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 10, 2025

Mar 10, 2025

Aligos Q4 Earnings: $105M Raise Backs Promising HBV Drug Results - StockTitan

Mar 10, 2025

Mar 10, 2025

Earnings Scheduled For March 10, 2025 - Benzinga

Mar 10, 2025

Mar 08, 2025

Aligos Therapeutics (ALGS) to Release Quarterly Earnings on Monday - Defense World

Mar 08, 2025

Mar 07, 2025

ALIGOS THERAPEUTICS Earnings Preview: Recent $ALGS Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 07, 2025

Mar 05, 2025

How the (ALGS) price action is used to our Advantage - Stock Traders Daily

Mar 05, 2025

Mar 05, 2025

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Up 23.7% in February - Defense World

Mar 05, 2025

Mar 03, 2025

Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025 - The Manila Times

Mar 03, 2025

Mar 03, 2025

Will Aligos Therapeutics Q4 Results Reveal Progress in Liver Disease Pipeline? - Stock Titan

Mar 03, 2025

Mar 02, 2025

Reviewing Aligos Therapeutics (NASDAQ:ALGS) & Editas Medicine (NASDAQ:EDIT) - Defense World

Mar 02, 2025

Feb 22, 2025

(ALGS) Trading Report - news.stocktradersdaily.com

Feb 22, 2025

Feb 19, 2025

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Decline in Short Interest - MarketBeat

Feb 19, 2025

Feb 19, 2025

Aligos Therapeutics looks to raise $105 million in private placement - MSN

Feb 19, 2025

Feb 17, 2025

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Down 13.2% in January - Defense World

Feb 17, 2025

Feb 14, 2025

Aligos Therapeutics Announces $105 Million Private Placement FinancingAligos Therapeutics, Inc. (NASDAQ: ALGS) recently disclosed a Securities Purchase Agreement engagement entailing a Private Placement offering. The agreement includes the issuan - Defense World

Feb 14, 2025

Feb 12, 2025

Aligos Therapeutics, Inc. announced that it expects to receive $105.003206 million in funding - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

Aligos Therapeutics secures $105 million in private placement By Investing.com - Investing.com Canada

Feb 12, 2025

Feb 12, 2025

Aligos Therapeutics secures $105 million in private placement - MSN

Feb 12, 2025

Feb 12, 2025

Aligos Therapeutics Secures $105M in Private Placement - TipRanks

Feb 12, 2025

Feb 12, 2025

Aligos Therapeutics rises after $105 million private placement - TradingView

Feb 12, 2025

Feb 12, 2025

Aligos Therapeutics announces $105M private placement financing - TipRanks

Feb 12, 2025

Feb 12, 2025

Aligos Therapeutics Announces $105 Million Private Placement Financing - The Manila Times

Feb 12, 2025

Feb 12, 2025

Major Funding Alert: Aligos Lands $105M Investment for Game-Changing Hepatitis B Drug Development - StockTitan

Feb 12, 2025

Feb 12, 2025

Trading (ALGS) With Integrated Risk Controls - Stock Traders Daily

Feb 12, 2025

Feb 08, 2025

Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely - Yahoo Canada Finance

Feb 08, 2025

Feb 04, 2025

Aligos Therapeutics patents new inhibitors of PD-1, PD-L1 or PD-1/PD-L1 interaction - BioWorld Online

Feb 04, 2025

Feb 04, 2025

PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? - Yahoo Finance

Feb 04, 2025